Mounjaro, Ozempic, Wegovy, Zepbound: What’s the Difference?
Here’s a clear breakdown of the key differences between Mounjaro, Ozempic, Wegovy, and Zepbound — all popular injectable medications for type 2 diabetes and weight loss:
1. Active Ingredients
| Medication | Active Ingredient | Drug Class |
|---|---|---|
| Mounjaro | Tirzepatide | Dual GIP and GLP-1 receptor agonist |
| Zepbound | Tirzepatide | Dual GIP and GLP-1 receptor agonist |
| Ozempic | Semaglutide | GLP-1 receptor agonist |
| Wegovy | Semaglutide | GLP-1 receptor agonist |
Summary:
-
Mounjaro and Zepbound contain tirzepatide.
-
Ozempic and Wegovy contain semaglutide.
-
Both work by mimicking hormones that regulate blood sugar and appetite, but tirzepatide acts on two receptors (GIP + GLP-1), while semaglutide acts on one (GLP-1).
⚕️ 2. Approved Uses
| Medication | Approved For | Main Purpose |
|---|---|---|
| Mounjaro | Type 2 diabetes | Blood sugar control; off-label for weight loss |
| Zepbound | Chronic weight management | Weight loss in adults with obesity or overweight + related conditions |
| Ozempic | Type 2 diabetes | Blood sugar control; off-label for weight loss |
| Wegovy | Chronic weight management | Weight loss and obesity management |
Summary:
-
Mounjaro and Ozempic → officially for diabetes, but often used off-label for weight loss.
-
Zepbound and Wegovy → officially for weight loss.
⚖️ 3. Weight Loss Effectiveness
| Medication | Average Weight Loss in Studies |
|---|---|
| Mounjaro / Zepbound (tirzepatide) | Up to 22% of body weight |
| Wegovy / Ozempic (semaglutide) | Up to 15% of body weight |
Summary:
Tirzepatide-based drugs (Mounjaro/Zepbound) generally show greater weight loss compared to semaglutide-based ones (Ozempic/Wegovy).
4. Dosage & Administration
-
All are once-weekly injections.
-
Dose gradually increases over several weeks to minimize side effects (like nausea).
-
Administered via subcutaneous injection (stomach, thigh, or upper arm).
⚠️ 5. Side Effects
Common:
-
Nausea
-
Vomiting
-
Diarrhea or constipation
-
Loss of appetite
Serious (rare):
-
Pancreatitis
-
Gallbladder issues
-
Possible thyroid tumors (warning label)
6. Cost & Availability
| Medication | Average Monthly Cost (without insurance) |
|---|---|
| Mounjaro | ~$1,000–1,200 |
| Zepbound | ~$1,000–1,100 |
| Ozempic | ~$900–1,000 |
| Wegovy | ~$1,300–1,400 |
Note: Prices vary depending on insurance, pharmacy, and country.
7. Summary Comparison Table
| Feature | Mounjaro | Zepbound | Ozempic | Wegovy |
|---|---|---|---|---|
| Ingredient | Tirzepatide | Tirzepatide | Semaglutide | Semaglutide |
| FDA Approved For | Type 2 Diabetes | Weight Loss | Type 2 Diabetes | Weight Loss |
| Weight Loss % | Up to 22% | Up to 22% | Up to 15% | Up to 15% |
| Class | GIP + GLP-1 agonist | GIP + GLP-1 agonist | GLP-1 agonist | GLP-1 agonist |
| Frequency | Weekly | Weekly | Weekly | Weekly |
✅ Bottom Line
-
For Diabetes: Mounjaro or Ozempic.
-
For Weight Loss: Zepbound or Wegovy.
-
For Maximum Weight Loss: Tirzepatide-based options (Mounjaro/Zepbound) typically outperform semaglutide-based ones.
